-The Economic Times A high-level panel set up after last month's gang-rape case in Delhi may have made headlines for not recommending the death penalty for rapists, but it is triggering concerns across India Inc for advocating far-reaching changes in rules that govern sexual harassment in corporate workplaces. The panel headed by former Supreme Court chief justice JSVerma, in its report submitted to the government, has said employers must not attempt conciliation...

-PTI Criticising the land acquisition bill cleared by the Cabinet, social activist Medha Patkar today said it has left many basic issues of conflict over forcible land acquisition unresolved. "It is also against the Parliamentary democracy that a unanimous report of the Standing Committee is not given due importance before finalising the draft and approving by the cabinet," she said in a release. "We would also like to point out that whole process...

-Pratirodh.com Biometric data based 12 digit Unique Identification (UID)-Aadhaar Number linked welfare schemes is being bulldozed with 2014 elections in mind with the ulterior motive of altering voting behavior of the citizens by creating a ‘universal identity infrastructure’ linked to ‘unified payment infrastructure’.   Ahead of next parliamentary elections, with the launch of 21st crore UID-Aadhaar Number and Aadhaar Enabled Service Delivery (AESD) on October 20, 2012 contemptuously ignores Parliament, Parliamentary Committee,...

-The Hindu The debate on the pros and cons of genetically engineered/modified crops is universal. In India, in the face of vociferous protests, the controversy has only deepened leading to a moratorium on cultivation of Bt Brinjal crop — the first GM food crop sought to be commercialised. Gargi Parsai spoke to Basudeb Acharia, Chairman of the Parliamentary Standing Committee on Agriculture, on its new report, “Cultivation of Genetically Modified Food...

-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials.  According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...